Resveratrol: Nutraceutical believed to counteract the detrimental effects of high-fat diet

Lipid Technology

Volumn 26, Issue 1, 2014, Pages 15-17

  Silk, Jennifer J ^a   Smoliga, James M ^a  

^a HIGH POINT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL APPLICATIONS; NUTRITION;

ANTI-INFLAMMATORIES; ANTICANCER EFFECTS; BENEFICIAL EFFECTS; CHRONIC DISEASE; CLINICAL TRIAL; LABORATORY MODELS; MULTIPLE DISCIPLINES; NUTRACEUTICALS;

RESVERATROL;

EID: 84893066124     PISSN: 0956666X     EISSN: 18635377     Source Type: Journal    
DOI: 10.1002/lite.201300315     Document Type: Article

References (17)

1. Baur, J. A., D. A. Sinclair, Nat Rev Drug Discov 2006, 5, 493.
2. Smoliga, J. M., J. A. Baur, H. A. Hausenblas, Mol Nutr Food Res 2011, 55, 1129.
3. Timmers, S. et al., Cell Metab 2011, 14, 612.
4. Bhatt, J. K., S. Thomas, M. J. Nanjan, Nutr Res 2012, 32, 537.
5. Brasnyo, P. et al., Br J Nutr 2011, 106, 383.
6. Crandall, J. P. et al., J Gerontol A Biol Sci Med Sci 2012, 67, 1307.
7. Konings, E. et al., Int J Obes (Lond) 2013.
8. Magyar, K. et al., Clin Hemorheol Microcirc 2012, 50, 179.
9. Tome-Carneiro, J. et al., Cardiovasc Drugs Ther 2013, 27, 37.
10. Elmadhun, N. Y. et al., Ann N Y Acad Sci 2013, 1290, 130.
11. Agarwal, B. et al., Int J Cardiol 2013, 166, 246.
12. Tome-Carneiro, J. et al., Am J Cardiol 2012, 110, 356.
13. Smoliga, J. M., E. S. Colombo, M. J. Campen, Aging (Albany NY) 2013, 495.
14. Kennedy, D. O. et al., American Journal of Clinical Nutrition 2010, 91, 1590.
15. Wong, R. H. et al., Nutr Metab Cardiovasc Dis 2011, 21, 851.
16. Brown, V. A. et al., Cancer Res 2010, 70, 9003.
17. Boocock, D. J. et al., Cancer Epidemiology, Biomarkers & Prevention 2007, 16, 1246.